• Our products

  • 1

Immunology

CIMZIA® (certolizumab pegol) is a Tumor Necrosis Factor (TNF) blocker. Cimzia is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis; for the treatment of adult patients with active psoriatic arthritis; for the treatment of adult patients with active ankylosing spondylitis. 

*for full prescribing information please refer to your locally approved label*

 

Product

  • 1

 

MEET US AT

ASCO & BIO Int’l Events

President & CEO along with BD Director of NewBridge Pharmaceuticals will attend this year events

From May 31-2 June, 2019

From June 3-6, 2019

Contact us on info@nbpharma.com if you would like to schedule a 1:1 meeting